DE60224509D1 - Imidazolderivate verwendbar als histamin h3 rezeptorliganden - Google Patents
Imidazolderivate verwendbar als histamin h3 rezeptorligandenInfo
- Publication number
- DE60224509D1 DE60224509D1 DE60224509T DE60224509T DE60224509D1 DE 60224509 D1 DE60224509 D1 DE 60224509D1 DE 60224509 T DE60224509 T DE 60224509T DE 60224509 T DE60224509 T DE 60224509T DE 60224509 D1 DE60224509 D1 DE 60224509D1
- Authority
- DE
- Germany
- Prior art keywords
- histamine
- receptor ligands
- imidazole derivatives
- derivatives use
- sub
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/70—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27980201P | 2001-03-29 | 2001-03-29 | |
US279802P | 2001-03-29 | ||
PCT/US2002/009026 WO2002079168A1 (en) | 2001-03-29 | 2002-03-22 | Imidazolyl derivatives useful as histamine h3 receptor ligands |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60224509D1 true DE60224509D1 (de) | 2008-02-21 |
DE60224509T2 DE60224509T2 (de) | 2009-03-05 |
Family
ID=23070480
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60224509T Expired - Lifetime DE60224509T2 (de) | 2001-03-29 | 2002-03-22 | Imidazolderivate verwendbar als histamin h3 rezeptorliganden |
Country Status (11)
Country | Link |
---|---|
US (2) | US20020198237A1 (de) |
EP (1) | EP1373218B9 (de) |
JP (1) | JP4653935B2 (de) |
AT (1) | ATE383343T1 (de) |
CA (1) | CA2442326C (de) |
CY (1) | CY1107362T1 (de) |
DE (1) | DE60224509T2 (de) |
DK (1) | DK1373218T3 (de) |
ES (1) | ES2299596T3 (de) |
PT (1) | PT1373218E (de) |
WO (1) | WO2002079168A1 (de) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007536270A (ja) | 2004-05-07 | 2007-12-13 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | イミダゾール誘導体のスケールアップ可能な合成 |
BRPI0515489A (pt) | 2004-09-20 | 2008-07-29 | Xenon Pharmaceuticals Inc | derivados heterocìclicos e sua utilização como inibidores de estearoil-coa desaturase |
CA2580857A1 (en) | 2004-09-20 | 2006-09-28 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
CN101083992A (zh) * | 2004-09-20 | 2007-12-05 | 泽农医药公司 | 抑制人硬脂酰CoA去饱和酶的哒嗪衍生物 |
EP1707203A1 (de) * | 2005-04-01 | 2006-10-04 | Bioprojet | Verwendung von Alkylaminen, die kein Imidazole enthalten, als Histamin H3 Rezeptor Liganden, zur Behandlung von Morbus Parkinson, obstruktiver Schlafapnoe, vaskularer Demenz, Demenz mit Lewy Korpen |
WO2007130075A1 (en) | 2005-06-03 | 2007-11-15 | Xenon Pharmaceuticals Inc. | Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3714179A (en) * | 1970-09-08 | 1973-01-30 | Searle & Co | 1-alkyl-2-furfurylthioimidazoles and congeners |
US3886160A (en) * | 1972-09-28 | 1975-05-27 | Searle & Co | 2-(2-Methyl-5-nitro-1-imidazolyl) ethyl-2-thiopseudoureas |
JP2813747B2 (ja) * | 1989-05-22 | 1998-10-22 | 富士写真フイルム株式会社 | 画像形成法 |
US5030644A (en) * | 1989-07-31 | 1991-07-09 | Merck & Co., Inc. | Imidazole compounds and their use as transglutaminase inhibitors |
US5352707A (en) | 1992-03-26 | 1994-10-04 | Harbor Branch Oceanographic Institution, Inc. | Method for treating airway congestion |
US5217986A (en) | 1992-03-26 | 1993-06-08 | Harbor Branch Oceanographic Institution, Inc. | Anti-allergy agent |
US5869479A (en) * | 1997-08-14 | 1999-02-09 | Schering Corporation | Treatment of upper airway allergic responses |
FR2771093B1 (fr) * | 1997-11-19 | 2000-01-21 | Synthelabo | Derives d'imidazole, leur preparation et leur application en therapeutique |
GB9803536D0 (en) * | 1998-02-19 | 1998-04-15 | Black James Foundation | Histamine H,receptor ligands |
EP0978512A1 (de) | 1998-07-29 | 2000-02-09 | Societe Civile Bioprojet | Aryloxy- (oder Arylthio)alkylamine ohne Imidazolring als Histamin-H3-Antagonisten und deren therapeutische Anwendung |
JP2007536270A (ja) * | 2004-05-07 | 2007-12-13 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | イミダゾール誘導体のスケールアップ可能な合成 |
-
2002
- 2002-03-22 US US10/104,283 patent/US20020198237A1/en not_active Abandoned
- 2002-03-22 ES ES02757803T patent/ES2299596T3/es not_active Expired - Lifetime
- 2002-03-22 WO PCT/US2002/009026 patent/WO2002079168A1/en active IP Right Grant
- 2002-03-22 PT PT02757803T patent/PT1373218E/pt unknown
- 2002-03-22 DE DE60224509T patent/DE60224509T2/de not_active Expired - Lifetime
- 2002-03-22 CA CA2442326A patent/CA2442326C/en not_active Expired - Lifetime
- 2002-03-22 EP EP02757803A patent/EP1373218B9/de not_active Expired - Lifetime
- 2002-03-22 AT AT02757803T patent/ATE383343T1/de active
- 2002-03-22 DK DK02757803T patent/DK1373218T3/da active
- 2002-03-22 JP JP2002577795A patent/JP4653935B2/ja not_active Expired - Fee Related
-
2004
- 2004-01-14 US US10/757,625 patent/US7265135B2/en not_active Expired - Lifetime
-
2008
- 2008-03-26 CY CY20081100341T patent/CY1107362T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
EP1373218A1 (de) | 2004-01-02 |
JP2004524363A (ja) | 2004-08-12 |
DE60224509T2 (de) | 2009-03-05 |
US7265135B2 (en) | 2007-09-04 |
CY1107362T1 (el) | 2012-12-19 |
PT1373218E (pt) | 2008-02-21 |
CA2442326A1 (en) | 2002-10-10 |
ATE383343T1 (de) | 2008-01-15 |
DK1373218T3 (da) | 2008-05-19 |
US20020198237A1 (en) | 2002-12-26 |
WO2002079168A1 (en) | 2002-10-10 |
EP1373218B9 (de) | 2008-12-03 |
ES2299596T3 (es) | 2008-06-01 |
EP1373218B1 (de) | 2008-01-09 |
JP4653935B2 (ja) | 2011-03-16 |
US20040147577A1 (en) | 2004-07-29 |
CA2442326C (en) | 2012-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE384050T1 (de) | Benzazepinderivate als histamin-h3-antagonisten | |
ATE440087T1 (de) | 2,4-diaminopyrimidinderivate, die sich als inhibitoren von pkc-theta eignen | |
NO20021358L (no) | Alkylendiamin-substituerte heterocykler | |
ATE423769T1 (de) | Fluor- und sulfonylaminohaltige, 3,6- disubstituierte azabicyclo 3.1.0 hexanderivate als muscarinrezeptorantagonisten | |
HRP20041042A2 (en) | Novel substituted sulfamate anticonvulsant derivatives | |
DK1725536T3 (da) | Imidazolin-derivater med CB1-antagonistisk aktivitet | |
EA200500342A1 (ru) | Гетероциклические замещённые пиперазины для лечения шизофрении | |
EA200700047A1 (ru) | Новые алкильные производные в качестве метаботропных рецепторов глутамата | |
DE60237528D1 (de) | Neue aminoazetidin-, aminopyrrolidin- und aminopiperidinderivative | |
CY1109808T1 (el) | Αρυλινδενο-πυριδινες και αρυλινδενο-πυριμιδινες και η χρηση τους ως ανταγωνιστων των υποδοχεων αδενοσινης α2α | |
EA200501595A1 (ru) | Азабициклические производные в качестве антагонистов мускаринового рецептора | |
ATE368040T1 (de) | Substituierte tetrazyklische pyprolochinolonderivate als phosphodiesterase- inhibitoren | |
DE60308699D1 (en) | 2-phenylamino-4-trifluoromethyl-5-(benzyl- oder pyridin-4-ylmethyl)carbamoylpyrimidin-derivate als selektive cb2 cannabinoid-rezeptor modulatoren | |
EA200501593A1 (ru) | Азабициклические производные в качестве антагонистов мускаринового рецептора | |
CY1107362T1 (el) | Παραγωγα ιμιδαζολυλιου χρησιμα ως συνδετες υποδοχεων ισταμινης h3 | |
SG146627A1 (en) | Imidazole derivatives | |
DE502004007387D1 (de) | Triazolverbindungen und ihre therapeutische verwendung | |
ATE405551T1 (de) | Tetrasubstituierte imidazolderivate als cannabinoid-cb1-rezeptormodulatoren mit hoher cb1-/cb2-rezeptorsubtyp-selektivität | |
MXPA04001977A (es) | Antagonistas v de receptor ccr-3. | |
UA84737C2 (ru) | Производные имидазолина с антагонистической активностью относительно cb1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC., TI, US |
|
8364 | No opposition during term of opposition |